Free Trial
NASDAQ:CODX

Co-Diagnostics (CODX) Stock Price, News & Analysis

Co-Diagnostics logo
$0.29 +0.00 (+0.35%)
Closing price 07/3/2025 03:47 PM Eastern
Extended Trading
$0.28 0.00 (-1.39%)
As of 07/3/2025 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Co-Diagnostics Stock (NASDAQ:CODX)

Key Stats

Today's Range
$0.28
$0.30
50-Day Range
$0.23
$0.37
52-Week Range
$0.23
$2.23
Volume
384,882 shs
Average Volume
250,744 shs
Market Capitalization
$9.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Buy

Company Overview

Co-Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

CODX MarketRank™: 

Co-Diagnostics scored higher than 74% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Co-Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Co-Diagnostics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Co-Diagnostics' stock forecast and price target.
  • Earnings Growth

    Earnings for Co-Diagnostics are expected to grow in the coming year, from ($1.22) to ($1.17) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Co-Diagnostics is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Co-Diagnostics is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Co-Diagnostics has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Co-Diagnostics' valuation and earnings.
  • Percentage of Shares Shorted

    0.92% of the float of Co-Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Co-Diagnostics has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Co-Diagnostics has recently decreased by 27.93%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Co-Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Co-Diagnostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.92% of the float of Co-Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Co-Diagnostics has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Co-Diagnostics has recently decreased by 27.93%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Co-Diagnostics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 8.40% of the stock of Co-Diagnostics is held by insiders.

    • Percentage Held by Institutions

      Only 14.99% of the stock of Co-Diagnostics is held by institutions.

    • Read more about Co-Diagnostics' insider trading history.
    Receive CODX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Co-Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

    CODX Stock News Headlines

    CODX Co-Diagnostics, Inc. - Seeking Alpha
    $100 Trillion “AI Metal” Found in American Ghost Town
    Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
    See More Headlines

    CODX Stock Analysis - Frequently Asked Questions

    Co-Diagnostics' stock was trading at $0.75 at the beginning of the year. Since then, CODX stock has decreased by 61.7% and is now trading at $0.2870.

    Co-Diagnostics, Inc. (NASDAQ:CODX) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.33) by $0.09. The company earned $0.05 million during the quarter, compared to analyst estimates of $0.38 million. Co-Diagnostics had a negative trailing twelve-month return on equity of 60.16% and a negative net margin of 1,025.45%.
    Read the conference call transcript
    .

    Co-Diagnostics (CODX) raised $9 million in an initial public offering (IPO) on Thursday, July 13th 2017. The company issued 1,300,000 shares at a price of $6.35-$6.75 per share. WallachBeth Capital and Network 1 Securities acted as the underwriters for the IPO.

    Shares of CODX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Co-Diagnostics investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Moderna (MRNA), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

    Company Calendar

    Last Earnings
    5/08/2025
    Today
    7/06/2025
    Next Earnings (Estimated)
    8/06/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Medical Services
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:CODX
    Fax
    N/A
    Employees
    100
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $5.50
    High Stock Price Target
    $10.00
    Low Stock Price Target
    $1.00
    Potential Upside/Downside
    +1,816.4%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    3 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$37.64 million
    Net Margins
    -1,025.45%
    Pretax Margin
    -1,024.14%

    Debt

    Sales & Book Value

    Annual Sales
    $3.71 million
    Price / Cash Flow
    N/A
    Book Value
    $1.70 per share
    Price / Book
    0.17

    Miscellaneous

    Free Float
    30,753,000
    Market Cap
    $9.64 million
    Optionable
    Optionable
    Beta
    0.60

    Social Links

    Beginner's Guide To Retirement Stocks Cover

    Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

    Get This Free Report

    This page (NASDAQ:CODX) was last updated on 7/6/2025 by MarketBeat.com Staff
    From Our Partners